Access India Ventures

Ownership-Driven Early-Stage Investing in Indian HealthTech & Frontier & Enabling Technologies

Access India Ventures

Mission

Mission

Leverage India's growth through 2035 by investing in Agritech and Health Tech to address critical needs in a $430 billion market.

Leverage India's growth through 2035 by investing in Agritech and Health Tech to address critical needs in a $430 billion market.

Healthcare

Structural healthcare inefficiencies, institutional buyers, and repeatable exit pathways.

Frontier & Enabling Technologies

Software-led scalable platforms selected under the same ownership-driven investment discipline.

PROCESS

Our Approach

Our Approach

Strategy

• Evidence-based company selection
• Clear economic buyers
• Early commercial validation
• Repeatable revenue models
• Practical exit pathways

Our Team

• Global healthcare operating depth
• India venture execution expertise
• Local sourcing and diligence capabilities
• Sector-led investment leadership
• Disciplined portfolio construction

15 investments

• Broad sourcing across India
• Highly selective entry discipline
• Evidence-gated follow-on capital
• Concentrated conviction investing
• 12–15 core investments

Investment Stage

• HealthTech as core return engine
• Frontier & Enabling Technologies optionality
• Seed to Series A focus
• $250K–$750K initial checks
• Ownership-focused capital deployment

Team

AIV Members

AIV Members

Throughout our journey, we have successfully closed deals, navigated exits, and cultivated enduring relationships with our partners, clients, and stakeholders.

Throughout our journey, we have successfully closed deals, navigated exits, and cultivated enduring relationships with our partners, clients, and stakeholders.

Sid Varma

Investor at 77 Capital India, General Partner at Unilease family office. Previous experience at Commercial Bank of Dubai.

Sid Varma

Investor at 77 Capital India, General Partner at Unilease family office. Previous experience at Commercial Bank of Dubai.

Harry Paul

Former International senior roles at Roche and Boston Scientific, and CEO of Tharos. 3 years in India as General Manager for Boston Scientific.

Harry Paul

Former International senior roles at Roche and Boston Scientific, and CEO of Tharos. 3 years in India as General Manager for Boston Scientific.

Ram V

Bangalore–based Ram leads AIV’s tech-hub strategy, driving deal flow through Indian Institute of Science, IIT MedTech, and NSRCEL, backed by 25+ years in medtech, investing, and mentorship.

Ram V

Bangalore–based Ram leads AIV’s tech-hub strategy, driving deal flow through Indian Institute of Science, IIT MedTech, and NSRCEL, backed by 25+ years in medtech, investing, and mentorship.

Investment focus

Healthcare

Efficient care
AI for disease prevention
Longevity support
Data-driven hospital optimisation
Public health management

product
product
product

Investment focus

Frontier & Enabling Technologies

Software-led scalable platforms selected under the same ownership-driven investment discipline.

INVESTMENTS

Our Investments

Throughout our journey, we have successfully closed deals, navigated exits, and cultivated enduring relationships with our partners, clients, and stakeholders.

Track Record

  • company logo
  • company logo
  • company logo
  • company logo
  • company logo 1
  • company logo
  • company logo
  • company logo
logo

Transforming India's Tomorrow: Investing in Healthtech, Agritech, and Emerging Technologies

logo

Transforming India's Tomorrow: Investing in Healthtech, Agritech, and Emerging Technologies

logo

Transforming India's Tomorrow: Investing in Healthtech, Agritech, and Emerging Technologies